Latest News

  • Research finds genetic risk-factor overlap between Alzheimer’s and all-cause and vascular dementias

    Scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have reported the largest-ever genome-wide association study of dementia from all causes, revealing an overlap of genetic risks including neurodegeneration, vascular factors and cerebral small-vessel disease. Genome-wide association studies help scientists identify genes associated with a particular disease or [...]

  • Immunotherapy after surgery helps people live cancer-free longer

    Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free following surgical removal of the bladder. Researchers found that postsurgical treatment with pembrolizumab (Keytruda), which is approved by the Food and Drug Administration (FDA) for treating at [...]

  • New treatment extends ovarian function in older mice

    A new Northwestern Medicine study in mice has discovered a novel way to lengthen the “healthspan” of ovaries — improving maintenance of the ovaries and preventing key age-related changes in ovarian function. A woman’s ovaries are like a factory where eggs grow and produce hormones that regulate everything from menstruation and pregnancy to bone density [...]

  • Cow slime can help disc herniation patients after surgery

    Researchers have developed a gel inspired by cow slime for patients suffering from disc herniation. By adding the mucin gel immediately after surgery, it is possible to create a protective barrier around the discs to prevent the immune system from attacking their nucleus pulposus - keeping the discs intact and reducing the risk of further [...]

  • Socioeconomic inequality linked to increased risk of age-related macular degeneration

    A study has revealed a significant association between socioeconomic status (SES) inequality and the risk of developing age-related macular degeneration (AMD). The study highlights how a healthy lifestyle can mitigate some of the risks associated with low SES. Socioeconomic disparities have long been a concern in various health outcomes. This study, led by Associate Research [...]

  • Replacing ultra-processed foods in diet reduces type 2 diabetes risk

    People who eat more ultra-processed foods (UPF) are at increased risk of developing type 2 diabetes, but this risk can be lowered by consuming less processed foods instead, a new study has found. The study investigated the relationship between the degree of food processing and type 2 diabetes risk, including which kinds of UPF were [...]

  • Post-surgery recovery: Essential aspects to keep in mind

    Undergoing surgery is never easy, and your body goes through a lot during the medical procedure - and after it. It’s not uncommon for many people to experience anxiety when finding out about the upcoming procedure, causing them to worry excessively about the surgery itself as well as the risks associated with it, such as [...]

  • FDA authorises first OTC hearing aid software for use with Apple headphones

    The U.S. Food and Drug Administration (FDA) has authorised the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customised to the user's hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve [...]

  • Phase 3 clinical trial expected for Stargardt Macular Degeneration treatment

    Nanoscope Therapeutics has announced the expected advancement of MCO-010 for the treatment of Stargardt Macular Degeneration (SMD) to a Phase 3 registrational trial following a productive end-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA).  Nanoscope Therapeutics has said that the FDA provided clear input on the proposed Phase 3 registrational trial [...]

  • NeuFit introduces a new approach to treating neuropathy

    NeuFit has unveiled an innovative approach for treating neuropathy that integrates advanced diagnostics and therapeutic technologies. The NEUBIE (Neuro-Bio-Electric Stimulator) is a device that utilises direct current (DC) electrical stimulation to promote accelerated recovery, enhance performance, and improve overall wellbeing. Unlike conventional methods that primarily focus on structural rehabilitation, the NEUBIE targets the nervous system, [...]